November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at firstname.lastname@example.org)
October 01, 2016
Lavrov tells Kerry that any lax attitude towards Jabhat al-Nusra unacceptable
LAVROV TELLS KERRY BY PHONE THAT ATTEMPTS BY WESTERN-GUIDED OPPOSITION FORCES TO TOLERATE JABHAT AL-NUSRA, THEIR LINE TOWARDS BLOCKING INTRA-SYRIAN TALKS ARE UNACCEPTABLE - RUSSIAN FOREIGN MINISTRY
Synagogue attacked in Moscow - source (Part 2)
Russia's Communications Ministry views positively termination of contract between U.S., ICANN
Synagogue attacked in Moscow - source
Russia women's national handball team that won gold in Rio passes all doping tests - IHF head
Moldovan minister of finance doused with milk
Chisinau asks Bucharest for assistance in ensuring Russian troops' withdrawal from Transdniestria
Russia ready to conclude new contract with NASA to deliver astronauts to ISS - expert
Self-proclaimed Luhansk republic: Separation of forces in village of Zolote completed (Part 2)
Russian-Turkish intergovernmental commission meeting planned in Istanbul in a week - Russian deputy minister
Ukrainian govt forces don't allow OSCE monitors to cross bridge near Luhansk
Kyiv says its positions in Donbas keep being shelled